Drug Profile
PF 6305591
Alternative Names: PF-06305591; PF-6305591Latest Information Update: 11 Mar 2014
Price :
$50
*
At a glance
- Originator Pfizer
- Class Analgesics
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 28 Feb 2014 Discontinued - Phase-I for Pain in Belgium (PO, liquid)
- 28 Feb 2014 Discontinued - Phase-I for Pain in Belgium (PO, tablet)
- 30 Nov 2013 Pfizer completes a phase I trial in healthy volunteers in Belgium (NCT01776619)